Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

E. J. Sorenson; A. J. Windbank; J. N. Mandrekar; W. R. Bamlet; S. H. Appel; C. Armon; P. E. Barkhaus; P. Bosch; K. Boylan; W. S. David; E. Feldman; J. Glass; L. Gutmann; J. Katz; W. King; C. A. Luciano; L. F. McCluskey; S. Nash; D. S. Newman; R. M. Pascuzzi; E. Pioro; L. J. Sams; S. Scelsa; E. P. Simpson; S. H. Subramony; E. Tiryaki; C. A. Thornton

doi:10.1212/01.wnl.0000335970.78664.36

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

E. J. Sorenson, A. J. Windbank, J. N. Mandrekar, W. R. Bamlet, S. H. Appel, C. Armon, P. E. Barkhaus, P. Bosch, K. Boylan, W. S. David, E. Feldman, J. Glass, L. Gutmann, J. Katz, W. King, C. A. Luciano, L. F. McCluskey, S. Nash, D. S. Newman, R. M. PascuzziE. Pioro, L. J. Sams, S. Scelsa, E. P. Simpson, S. H. Subramony, E. Tiryaki, C. A. Thornton

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1770-1775
Number of pages	6
Journal	Neurology
Volume	71
Issue number	22
DOIs	https://doi.org/10.1212/01.wnl.0000335970.78664.36
State	Published - Nov 25 2008
Externally published	Yes

ASJC Scopus Subject Areas

Clinical Neurology

Access to Document

10.1212/01.wnl.0000335970.78664.36

OpenUrl availability

Full text

Cite this

Sorenson, E. J., Windbank, A. J., Mandrekar, J. N., Bamlet, W. R., Appel, S. H., Armon, C., Barkhaus, P. E., Bosch, P., Boylan, K., David, W. S., Feldman, E., Glass, J., Gutmann, L., Katz, J., King, W., Luciano, C. A., McCluskey, L. F., Nash, S., Newman, D. S., ... Thornton, C. A. (2008). Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology, 71(22), 1770-1775. https://doi.org/10.1212/01.wnl.0000335970.78664.36

Sorenson, EJ, Windbank, AJ, Mandrekar, JN, Bamlet, WR, Appel, SH, Armon, C, Barkhaus, PE, Bosch, P, Boylan, K, David, WS, Feldman, E, Glass, J, Gutmann, L, Katz, J, King, W, Luciano, CA, McCluskey, LF, Nash, S, Newman, DS, Pascuzzi, RM, Pioro, E, Sams, LJ, Scelsa, S, Simpson, EP, Subramony, SH, Tiryaki, E & Thornton, CA 2008, 'Subcutaneous IGF-1 is not beneficial in 2-year ALS trial', Neurology, vol. 71, no. 22, pp. 1770-1775. https://doi.org/10.1212/01.wnl.0000335970.78664.36

@article{906ba13a14674e9b812f3bf499cf4cb9,

title = "Subcutaneous IGF-1 is not beneficial in 2-year ALS trial",

author = "Sorenson, {E. J.} and Windbank, {A. J.} and Mandrekar, {J. N.} and Bamlet, {W. R.} and Appel, {S. H.} and C. Armon and Barkhaus, {P. E.} and P. Bosch and K. Boylan and David, {W. S.} and E. Feldman and J. Glass and L. Gutmann and J. Katz and W. King and Luciano, {C. A.} and McCluskey, {L. F.} and S. Nash and Newman, {D. S.} and Pascuzzi, {R. M.} and E. Pioro and Sams, {L. J.} and S. Scelsa and Simpson, {E. P.} and Subramony, {S. H.} and E. Tiryaki and Thornton, {C. A.}",

note = "Funding Information: Supported by NIH grant # RO1 NS 42759 and by a grant from the ALS Association. ",

year = "2008",

month = nov,

day = "25",

doi = "10.1212/01.wnl.0000335970.78664.36",

language = "English",

volume = "71",

pages = "1770--1775",

journal = "Neurology",

issn = "0028-3878",

number = "22",

}

TY - JOUR

T1 - Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

AU - Sorenson, E. J.

AU - Windbank, A. J.

AU - Mandrekar, J. N.

AU - Bamlet, W. R.

AU - Appel, S. H.

AU - Armon, C.

AU - Barkhaus, P. E.

AU - Bosch, P.

AU - Boylan, K.

AU - David, W. S.

AU - Feldman, E.

AU - Glass, J.

AU - Gutmann, L.

AU - Katz, J.

AU - King, W.

AU - Luciano, C. A.

AU - McCluskey, L. F.

AU - Nash, S.

AU - Newman, D. S.

AU - Pascuzzi, R. M.

AU - Pioro, E.

AU - Sams, L. J.

AU - Scelsa, S.

AU - Simpson, E. P.

AU - Subramony, S. H.

AU - Tiryaki, E.

AU - Thornton, C. A.

N1 - Funding Information: Supported by NIH grant # RO1 NS 42759 and by a grant from the ALS Association.

PY - 2008/11/25

Y1 - 2008/11/25

UR - http://www.scopus.com/inward/record.url?scp=58149242839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149242839&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000335970.78664.36

DO - 10.1212/01.wnl.0000335970.78664.36

M3 - Article

C2 - 19029516

AN - SCOPUS:58149242839

SN - 0028-3878

VL - 71

SP - 1770

EP - 1775

JO - Neurology

JF - Neurology

IS - 22

ER -

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this